{"query": "Dr Reddy Share Price Highlights : Dr Reddy closed today at ₹1240.65, up 0.37% from yesterday's ₹1236.10 | Stock Market News", "similar": [{"title": "Bajaj Finance’s first-quarter net profit surges 159% y-o-y to Rs 2,596 cr", "date": "2022-07-27 19:17:13.000", "impact": "-6.56%"}, {"title": "Tata Motors shares surged 800% from pandemic low; more upside likely?", "date": "2023-06-22 17:30:00.000", "impact": "+0.87%"}, {"title": "Tata Motors shares climb 16% in January; can they cross Rs 500 mark?", "date": "2023-02-01 17:30:00.000", "impact": "+0.89%"}]}
{"query": "Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe", "similar": [{"title": "Dr Reddy’s Laboratories, Prestige BioPharma to commercialize Trastuzumab biosimilar", "date": "2021-12-09 09:20:00", "impact": "-0.35%"}, {"title": "Dr Reddy’s Laboratories launches Sorafenib tablets in UK market", "date": "2022-06-14 14:20:06", "impact": "-4.08%"}, {"title": "Dr Reddy’s Lab completes Phase 1 study of proposed arthritis drug", "date": "2022-12-19 14:07:00", "impact": "-0.79%"}]}
{"query": "Dr Reddy's in pact with Shanghai Henlius Biotech for exclusive US, Europe rights for daratumumab biosimil", "similar": [{"title": "Dr Reddy’s Laboratories, Prestige BioPharma to commercialize Trastuzumab biosimilar", "date": "2021-12-09 09:20:00", "impact": "-0.35%"}, {"title": "Why stock market experts are bullish on Dr. Reddy’s shares? Key levels to watch", "date": "2021-09-06 14:07:22", "impact": "-0.57%"}, {"title": "Dr Reddy’s to sell US, Canada territory rights for migraine drug to BDSI", "date": "2021-08-04 21:31:00", "impact": "+1.00%"}]}
